Title:
【発明の名称】変性されたシアリルルイスx化合物
Document Type and Number:
Japanese Patent JPH06510744
Kind Code:
A
Abstract:
The present invention is drawn to methods for the synthesis of sialyl Lewisx derivatives modified at the C-2 and/or C-6 position of GlcNAc employing chemo-enzymatic synthesis. The derivatives find use in the treatment and prevention of diseases.
More Like This:
| JPH10287575 | ANTIOBESTIC DRUG |
| WO/1992/022651 | ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE RAS GENE |
| WO/2005/009476 | INTRAVASCULAR DELIVERY OF NON-VIRAL NUCLEIC ACID |
Inventors:
Benot, Andre, Pee.
Niclad, Pandurang, Buoy.
Cashem, Mohammed, A.
Niclad, Pandurang, Buoy.
Cashem, Mohammed, A.
Application Number:
JP51068292A
Publication Date:
December 01, 1994
Filing Date:
June 09, 1992
Export Citation:
Assignee:
Glycomed Incorporated
International Classes:
A61K31/70; A61K31/702; A61K31/7028; A61K38/00; A61K39/385; A61K39/39; A61P37/00; C07H3/06; C07H15/04; C07H19/10; C07H19/20; C12P19/26; A61K39/00; (IPC1-7): C07H3/06; A61K31/70; A61K37/02; A61K39/385; C07H15/04; C12P19/26
Attorney, Agent or Firm:
Akira Asamura (3 outside)